Order Article Reprints

Gomzikova MO, Kletukhina SK, Kurbangaleeva SV, Neustroeva OA, Vasileva OS, Garanina EE, Khaiboullina SF, Rizvanov AA. Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and Proliferation of Human Mononuclear Cells. Pharmaceutics. 2020; 12(6):577. https://doi.org/10.3390/pharmaceutics12060577

Gomzikova, Marina O., Sevindzh K. Kletukhina, Sirina V. Kurbangaleeva, Olga A. Neustroeva, Olga S. Vasileva, Ekaterina E. Garanina, Svetlana F. Khaiboullina, and Albert A. Rizvanov. 2020. "Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and Proliferation of Human Mononuclear Cells" Pharmaceutics 12, no. 6: 577. https://doi.org/10.3390/pharmaceutics12060577

Gomzikova, M. O., Kletukhina, S. K., Kurbangaleeva, S. V., Neustroeva, O. A., Vasileva, O. S., Garanina, E. E., Khaiboullina, S. F., & Rizvanov, A. A. (2020). Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and Proliferation of Human Mononuclear Cells. Pharmaceutics, 12(6), 577. https://doi.org/10.3390/pharmaceutics12060577